Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Longfengtang Traditional Chinese Medicine is a prominent pharmaceutical company focused on the modernization, research, and large-scale production of Traditional Chinese Medicine (TCM). As a core subsidiary of the Yangtze River Pharmaceutical Group (YRPG), it operates one of the most advanced TCM manufacturing bases in China, integrating automated extraction and intelligent production lines. The company is best known for its market-leading respiratory and anti-inflammatory products, including Lanqin Oral Liquid and Suhuang Zhike Capsules. Longfengtang emphasizes high-quality standards and clinical evidence, aiming to bridge traditional herbal knowledge with modern pharmaceutical science. Its operations span the entire value chain, from standardized herbal cultivation to global commercial distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Longfengtang Traditional Chinese Medicine.